Literature DB >> 17036048

Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor.

Pablo Pelegrin1, Annmarie Surprenant.   

Abstract

P2X(7) receptors are ATP-gated cation channels; their activation in macrophage also leads to rapid opening of a membrane pore permeable to dyes such as ethidium, and to release of the pro-inflammatory cytokine, interleukin-1beta (IL-1beta). It has not been known what this dye-uptake path is, or whether it is involved in downstream signalling to IL-1beta release. Here, we identify pannexin-1, a recently described mammalian protein that functions as a hemichannel when ectopically expressed, as this dye-uptake pathway and show that signalling through pannexin-1 is required for processing of caspase-1 and release of mature IL-1beta induced by P2X(7) receptor activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036048      PMCID: PMC1630421          DOI: 10.1038/sj.emboj.7601378

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Pannexin 1 in erythrocytes: function without a gap.

Authors:  Silviu Locovei; Li Bao; Gerhard Dahl
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 2.  P2Z purinoceptors.

Authors:  S E Hickman; C E Semrad; S C Silverstein
Journal:  Ciba Found Symp       Date:  1996

3.  Antiapoptotic effect of benzyloxycarbonyl-aspartyl-(beta-tertier-butyl ester)-bromomethylketone (Z-D(OtBu)-Bmk), an intermediate of interleukin-1 beta converting enzyme inhibitors.

Authors:  K Németh; G Bugovics; J I Székely
Journal:  Int J Immunopharmacol       Date:  1997-04

4.  Intracellular ATP levels determine cell death fate by apoptosis or necrosis.

Authors:  Y Eguchi; S Shimizu; Y Tsujimoto
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

5.  Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages.

Authors:  E C Beyer; T H Steinberg
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

6.  Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore.

Authors:  W P Schilling; T Wasylyna; G R Dubyak; B D Humphreys; W G Sinkins
Journal:  Am J Physiol       Date:  1999-10

7.  Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes.

Authors:  B D Humphreys; G R Dubyak
Journal:  J Leukoc Biol       Date:  1998-08       Impact factor: 4.962

8.  Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.

Authors:  D Perregaux; C A Gabel
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

9.  Blockade of human P2X7 receptor function with a monoclonal antibody.

Authors:  G Buell; I P Chessell; A D Michel; G Collo; M Salazzo; S Herren; D Gretener; C Grahames; R Kaur; M H Kosco-Vilbois; P P Humphrey
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

10.  Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing.

Authors:  D G Perregaux; L Svensson; C A Gabel
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

View more
  600 in total

1.  P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells.

Authors:  Safina Gadeock; Aleta Pupovac; Vanessa Sluyter; Mari Spildrejorde; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-06-05       Impact factor: 3.765

2.  Pannexins in ischemia-induced neurodegeneration.

Authors:  Panagiotis Bargiotas; Antje Krenz; Sheriar G Hormuzdi; Dirk A Ridder; Anne Herb; Waleed Barakat; Silvia Penuela; Jakob von Engelhardt; Hannah Monyer; Markus Schwaninger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

3.  Purinergic signaling: a fundamental mechanism in neutrophil activation.

Authors:  Yu Chen; Yongli Yao; Yuka Sumi; Andrew Li; Uyen Kim To; Abdallah Elkhal; Yoshiaki Inoue; Tobias Woehrle; Qin Zhang; Carl Hauser; Wolfgang G Junger
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

4.  P2X7 receptor-pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization.

Authors:  V Poornima; M Madhupriya; S Kootar; G Sujatha; Arvind Kumar; Amal Kanti Bera
Journal:  J Mol Neurosci       Date:  2011-09-20       Impact factor: 3.444

5.  Both sides now: multiple interactions of ATP with pannexin-1 hemichannels. Focus on "A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP".

Authors:  George R Dubyak
Journal:  Am J Physiol Cell Physiol       Date:  2009-02       Impact factor: 4.249

6.  Physical basis of apparent pore dilation of ATP-activated P2X receptor channels.

Authors:  Mufeng Li; Gilman E S Toombes; Shai D Silberberg; Kenton J Swartz
Journal:  Nat Neurosci       Date:  2015-09-21       Impact factor: 24.884

7.  Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7.

Authors:  Sahil Adriouch; Felix Scheuplein; Robert Bähring; Michel Seman; Olivier Boyer; Friedrich Koch-Nolte; Friedrich Haag
Journal:  Purinergic Signal       Date:  2009-02-21       Impact factor: 3.765

8.  Panx1 regulates cellular properties of keratinocytes and dermal fibroblasts in skin development and wound healing.

Authors:  Silvia Penuela; John J Kelly; Jared M Churko; Kevin J Barr; Amy C Berger; Dale W Laird
Journal:  J Invest Dermatol       Date:  2014-02-12       Impact factor: 8.551

9.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

Review 10.  Crosstalk between autophagy and inflammasomes.

Authors:  Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Mol Cells       Date:  2013-11-06       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.